PHARM Y1 S1: Anticancer drugs Flashcards
how to determine which chemotherapeutic drug will be picked
- take some tumour cells
- screen diff drugs to determine whether they’ll be effective
examples of classic anticancer drugs
- alkylating agents + platinum compounds
- cytotoxic antibiotics
- anti-metabolites
- plant alkaloids
- hormonal antagonists (breast and prostate cancer) and glucocorticoids (blood cancers)
alkylating agents + platinum compounds
- insert alkyl group into DNA
- creates covalent cross-links b/n diagonal guanines on opposite strands > stress on DNA > apoptosis
- can work @ any part of cell cycle (non-specific)
- e.g. cyclophosphamide
- platinum compounds end in -platin e.g. cisplatin
cytotoxic antibiotics + example
- inhibit transcription + translation (G1 and G2)
- can also inhibit topoisomerase - DNA replication (S)
- too many side effects as a regular antibiotic so used for cancer
- e.g. doxorubicin
anti-metabolites
- substitute themselves into DNA replication pathway (S-phase)
- e.g. methotrexate (folate antagonist) and fluorouracil
plant alkaloids
- mitotic poisons: vinca alkaloids and taxanes: inhibit spindle formation (mitosis)
- topoisomerase inhibitors (S-phase)
how do hormonal antagonists work for breast cancer + give 2 examples
- selective oestrogen receptor modulator: tamoxifen: oestrogen receptor antagonist in the breast, inhibiting breast cancer growth - G1
- anastrozole: inhibits aromatase which inhibits oestrogen production - G1
how do glucocorticoids work and give an example
- cause apoptosis
- most effective in blood borne cancers b/c they target lymphocytes
- prednisolone
how do hormonal antagonists work for prostate cancer + give 2 examples
- anti-androgens: bicalutamide: inhibit activity of androgens (class of hormones which includes testosterone) - G1 phase
- gonadotropin-releasing hormone (GnRH) analogues: competitively inhibits actions of GnRH, preventing sex hormone secretion
common symptoms of anticancer drugs
- target rapidly proliferating cells, therefore:
- hair loss
- mouth + GIT inflammation
- skin blistering + necrosis
- infertility
- N&V
novel anticancer drugs
- monoclonal antibodies
- immune therapy: interferons, interleukin 2 and checkpoint inhibitors
- protein kinase inhibitors
what is a mAb + 2 e.g.s
- react w/ specific target proteins on cancer cell
- can attach to + inactivate growth factor receptors on cancer cells > apoptosis
- can also attach a cytotoxic drug to the mAb which kills cancer cells
- trastuzumab: targets HER-2 receptors in breast cancer > increased immune response
- rituximab: binds to CD20 receptor on B cells in non-Hodgkin’s lymphoma > cell lysis
immune therapy
- boost own immune system to help it fight cancer
- cytokines: interferons + interleukin 2
- checkpoint inhibitors
what do interferons do
- secreted by monocytes
- increase cytotoxicity of NK cells, T cells + macrophages to kill cancer cells
what does interleukin-2 do
- secreted by CD4+ T cells
- causes increased proliferation of CD8+ T cells to be able to kill cancer cells by causing apoptosis
checkpoint inhibitors
- T cells contains proteins which stop the immune response (CTLA-4 and PD-1)
- checkpoint inhibitors inhibit these proteins to switch T cell function back on
protein kinase inhibitor
- inhibit protein kinases (e.g. tyrosine kinase) which are essential for cancer cell division
- restricted to leukaemia + GIT tumours
- some also inhibit angiogenesis
- suffix -inib
effect of anticancer drugs on organs
- heart: dysrhythmias
- lungs: toxicity
- renal failure
- nervous system: paraesthesia
- bladder: bleeding + inflammation
how to manage adverse effects of anticancer drugs
- analgesics
- antidepressants
- antiemetics (setrons) to prevent N&V
- colony stimulating factors (CSFs) e.g. erythropoietin or filigrastim (stimulate WBCs)
main complications w/ anticancer agents
- drug resistance by tumour
- tumour sanctuary: tumour cells grow in compartments inaccessible to drugs > creates relapse sites e.g. many drugs can’t cross BBB
- dose exhaustion: maximum dose combined w/ Pt’s immune system is still not enough to attack remaining cancer
how to overcome drug resistance
- use multiple cytotoxic drugs w/ diff mechanisms of action
- ‘drug holiday’ (take a break from drugs): cells may become more susceptible to drug
how to overcome tumour sanctuary
- treat w/ radiotherapy or surgery
how to overcome dose exhaustion
- use multiple cytotoxic drugs w/ diff mechanisms of action
- combine w/ radiotherapy/surgery
sensitising agents
- makes cells on outside of tumour more recognisable to immune system
- must be applied repeatedly as they only address the superficial layer of cells